GSK
841 hedge funds and large institutions have $10.4B invested in GSK in 2023 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 303 increasing their positions, 266 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
841
Holders Change
+19
Holders Change %
+2.31%
% of All Funds
13.41%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.19%
New
99
Increased
303
Reduced
266
Closed
69
Calls
$414M
Puts
$127M
Net Calls
+$287M
Net Calls Change
+$213M
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$160M |
| 2 |
Holocene Advisors
New York
|
+$76M |
| 3 |
Millennium Management
New York
|
+$54.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$45.1M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$130M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$104M |
| 3 |
JEST
JTC Employer Solutions Trustee
St Helier,
Jersey
|
-$46.6M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$46.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$45.3M |
